MedAvail Holdings, Inc.: Nasdaq/NYSE listing notice — MedAvail to be delisted from Nasdaq after Chapter 7 bankruptcy filing

MedAvail Holdings, Inc.

Filed voluntary Chapter 7 bankruptcy petition on Feb 2, 2024 in Delaware.
Nasdaq delisting notice cites public interest concerns and Chapter 7 filing.
Trading suspended at open on Feb 13, 2024; company will not appeal.
Form 25-NSE to be filed to remove common stock from Nasdaq listing.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

MedAvail Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

Exchange: nasdaq
Notice: delisting notice
Rules: 5101, 5110(b), IM-5101-1

Exact text from the filing

: MedAvail Holdings, Inc. , Case No. 24-10148. On February 2, 2024, the Company received written notice (the “Delisting Notice”) from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 7 Filing and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. In the Delisting Notice, the staff of Nasdaq referenced the Chapter 7 Filing and associated public interest concerns raised by it, concerns regarding the residual equity interest o

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-012286

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.